Following the end of the COVID-19 Public Health Emergency , the Future of Telemedicine for Some Gender-Affirming Hormone Therapy Remains Unclear
When the COVID-19 federal Public Health Emergency (PHE) ended on May 11th, the Drug Enforcement Administration (DEA) planned to roll-back PHE flexibility related to pre-pandemic restrictions on several prescribing practices. ...